These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 12779006)
1. Biomarkers in melanoma: staging, prognosis and detection of early metastases. Carlson JA; Slominski A; Linette GP; Mihm MC; Ross JS Expert Rev Mol Diagn; 2003 May; 3(3):303-30. PubMed ID: 12779006 [TBL] [Abstract][Full Text] [Related]
2. Molecular diagnostics in melanoma. Carlson JA; Ross JS; Slominski A; Linette G; Mysliborski J; Hill J; Mihm M J Am Acad Dermatol; 2005 May; 52(5):743-75; quiz 775-8. PubMed ID: 15858465 [TBL] [Abstract][Full Text] [Related]
3. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma]. Keijzer R; Bril H; van der Loo EM; de Graaf PW Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391 [TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary? Nahabedian MY; Tufaro AP; Manson PN Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009 [TBL] [Abstract][Full Text] [Related]
5. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123 [TBL] [Abstract][Full Text] [Related]
6. Stratification of patients by melanoma cell adhesion molecule (MCAM) expression on the basis of risk: implications for sentinel lymph node biopsy. Pearl RA; Pacifico MD; Richman PI; Wilson GD; Grover R J Plast Reconstr Aesthet Surg; 2008; 61(3):265-71. PubMed ID: 17569608 [TBL] [Abstract][Full Text] [Related]
7. [Sentinel node biopsy as a prognostic factor in cutaneous melanoma]. Avilés-Izquierdo JA; Lázaro-Ochaita P Actas Dermosifiliogr; 2009; 100(6):486-92. PubMed ID: 19709553 [TBL] [Abstract][Full Text] [Related]
8. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases. Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396 [TBL] [Abstract][Full Text] [Related]
9. Malignant melanoma 2003: predisposition, diagnosis, prognosis, and staging. Carlson JA; Slominski A; Linette GP; Mysliborski J; Hill J; Mihm MC; Ross JS Am J Clin Pathol; 2003 Dec; 120 Suppl():S101-27. PubMed ID: 15298147 [TBL] [Abstract][Full Text] [Related]
10. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level. Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789 [TBL] [Abstract][Full Text] [Related]
12. Systematic search for the best gene expression markers for melanoma micrometastasis detection. Soikkeli J; Lukk M; Nummela P; Virolainen S; Jahkola T; Katainen R; Harju L; Ukkonen E; Saksela O; Hölttä E J Pathol; 2007 Oct; 213(2):180-9. PubMed ID: 17891747 [TBL] [Abstract][Full Text] [Related]
13. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma. Caracò C; Marone U; Celentano E; Botti G; Mozzillo N Ann Surg Oncol; 2007 Sep; 14(9):2662-7. PubMed ID: 17597345 [TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study. Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169 [TBL] [Abstract][Full Text] [Related]
15. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma. Aloia TA; Gershenwald JE; Andtbacka RH; Johnson MM; Schacherer CW; Ng CS; Cormier JN; Lee JE; Ross MI; Mansfield PF J Clin Oncol; 2006 Jun; 24(18):2858-65. PubMed ID: 16782925 [TBL] [Abstract][Full Text] [Related]
16. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma. Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732 [TBL] [Abstract][Full Text] [Related]
17. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms. Gipponi M Minerva Chir; 2005 Aug; 60(4):217-33. PubMed ID: 16166921 [TBL] [Abstract][Full Text] [Related]
18. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma. Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039 [TBL] [Abstract][Full Text] [Related]
19. Molecular staging for patients with malignant melanoma. Shivers S; Jakub J; Pendas S; Reintgen D Expert Rev Anticancer Ther; 2007 Nov; 7(11):1665-74. PubMed ID: 18020932 [TBL] [Abstract][Full Text] [Related]
20. Pathologic analysis of sentinel lymph nodes in melanoma patients: current and future trends. Roberts AA; Cochran AJ J Surg Oncol; 2004 Mar; 85(3):152-61. PubMed ID: 14991887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]